Judy P Luden

Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia

R. Ware, R. Nieves, Teresa S Latham, 2017, JMIR research protocols.

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Scott T. Miller, Jamie L. Coleman, B. Davis, 2016, The Lancet.

TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, randomised controlled trial

Scott T. Miller, Jamie L. Coleman, B. Davis, 2015, Lancet (London, England).

Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: Baseline data from the BABY HUG trial

Scott T. Miller, R. Adams, C. Thornburg, 2009, Pediatric blood & cancer.

Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia

R. Adams, D. Brambilla, J. Seibert, 2001, Pediatric Radiology.

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Scott T. Miller, Jamie L. Coleman, B. Davis, 2015 .

Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study.

R. Adams, C. Pegelow, E. Vichinsky, 2004, Blood.